Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine ; volume:22 ; number:1 ; day:28 ; month:1 ; year:2022 ; pages:1-5 ; date:12.2022
BMC infectious diseases ; 22, Heft 1 (28.1.2022), 1-5, 12.2022
- Urheber
-
Lombardi, Andrea
Renisi, Giulia
Consonni, Dario
Oggioni, Massimo
Bono, Patrizia
Uceda Renteria, Sara
Piatti, Alessandra
Pesatori, Angela Cecilia
Castaldi, Silvana
Muscatello, Antonio
Riboldi, Luciano
Ceriotti, Ferruccio
Gori, Andrea
Bandera, Alessandra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-022-07083-1
- URN
-
urn:nbn:de:101:1-2022051321190670755027
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lombardi, Andrea
- Renisi, Giulia
- Consonni, Dario
- Oggioni, Massimo
- Bono, Patrizia
- Uceda Renteria, Sara
- Piatti, Alessandra
- Pesatori, Angela Cecilia
- Castaldi, Silvana
- Muscatello, Antonio
- Riboldi, Luciano
- Ceriotti, Ferruccio
- Gori, Andrea
- Bandera, Alessandra
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2
Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2
Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2
Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2
Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2